Dispute arbitration over the specific airdrop date of Lighter arises on Polymarket
According to Odaily, Lighter announced today the launch of its token LIT and has completed the airdrop. Based on Eastern Time, the probability of "Lighter airdrop on December 30" on Polymarket has reached as high as 95%. However, the specific airdrop date of Lighter has entered the UMA dispute resolution period on Polymarket.
A user has submitted a dispute to the UMA oracle regarding the determination of "Lighter airdrop on December 29" as "no," arguing that it should be determined as "yes." Calculated by Eastern Time, the Lighter airdrop occurred within about an hour before and after December 29 and December 30, which may have led to the controversy.
Note from Odaily: Polymarket relies on the UMA oracle to determine the outcome of events. After an event occurs, anyone can report the result to UMA. After the report is submitted, there will be a dispute period during which anyone who believes the report is incorrect can raise a dispute. If there is no dispute, the reported result will be accepted; if there is a dispute, UMA's dispute resolution mechanism will determine the final result. The dispute resolution process requires UMA token holders to vote on the correct outcome. UMA incentivizes honest behavior and penalizes malicious actions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
Crypto prices
More
